Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT06965556
Eligibility Criteria:
Inclusion Criteria:
* More than 18 years old
* Female
* Patient with early-stage breast cancer with preoperative pathology confirming invasive breast carcinoma or ductal carcinoma in situ
* No clinical or imaging evidence of distant metastasis
* Patients to receive breast surgery during hospitalizaiton (including mastectomy, breast conserving therapy, reconstrucion, etc.)
* Be able and willing to sign the Informed Consent Form (ICF)
Exclusion Criteria:
* Patients with locally advanced breast cancer to receive neoadjuvant therapy
* Patients currently participating in other clinical trials, which may have impact on the participation in this trial
* Previous history of breast cancer (patients with ipsilateral recurrence after breast sparing surgery)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06965556
Study Brief:
Protocol Section:
NCT06965556